The protective effects of dexmedetomidine on ischemic brain injury: A meta-analysis.

BACKGROUND Intracranial lesions, trauma or surgery-related damage activate immune inflammation and neuroendocrine responses, causing ischemic brain injury. Studies have shown that inflammatory cascade mediated by neuroendocrine hormones and proinflammatory mediators is implicated in the pathophysiology of ischemic brain injury. Alpha2-adrenoceptor agonists, dexmedetomidine, is widely used as neuroprotectants in anesthesia practice. However, it is still lack of a comprehensive meta-analysis to evaluate the neuroprotection of dexmedetomidine against ischemic brain injury via suppressing these two physiological responses. METHOD Searched the Cochrane Library, Pub-Med, EMBASE, EBSCO, Ovid, Chinese biological and medical database (CBM). Related literatures published in English or Chinese before January 2017 were enrolled. We assessed the quality of eligible studies and synthesized predefined outcomes with a random-effects model or fixed-effects model. RESULT Nineteen Randomized Controlled Trials including 879 patients were included. Findings for meta-analysis of various outcomes were summarised. Primary results shown that compared with placebo, dexmedetomidine reduced a surge of TNF-α [SMD=-2.34, 95%CI (-3.25, -1.44)], IL-6 [SMD=-2.44, 95%CI (-3.40, -1.47)], S100-β [SMD=-2.73, 95%CI (-3.65, -1.82)], NSE [SMD=-1.69, 95%CI (-2.77, -0.61)], cortisol [SMD=-2.48, 95%CI (-3.38, -1.58)] and glucose [SMD=-1.44, 95%CI (-1.85, -1.04)]; maintained the level of SOD [SMD=1.36, 95%CI (0.62, 2.10)]; decreased the rise in CRP level at postoperative one day. In response to stress reaction, dexmedetomidine attenuated the stress-related increasing of MAP, HR and intracranial pressure without significant effects on cerebral oxygen metabolism. CONCLUSION Alpha2-adrenoceptor agonists, dexmedetomidine, could reduce the release of inflammatory mediators and neuroendocrine hormones as well as maintain intracranial homoeostasis, alleviating ischemic brain injury and exerting an effect on brain protection.

[1]  Xiahong Luo,et al.  Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism , 2016, Clinical Neurology and Neurosurgery.

[2]  G. Wong,et al.  Dexmedetomidine Combined with General Anesthesia Provides Similar Intraoperative Stress Response Reduction When Compared with a Combined General and Epidural Anesthetic Technique , 2016, Anesthesia and analgesia.

[3]  Tinghua Wang,et al.  Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) improves brain ischemia-induced pulmonary injury in rats associated to TNF-α expression , 2016, Behavioral and Brain Functions.

[4]  J. Rocha,et al.  Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[5]  R. Thangavel,et al.  Neuroinflammation Induces Neurodegeneration. , 2016, Journal of neurology, neurosurgery and spine.

[6]  T. Kujala,et al.  Long-term influence of recurrent acute otitis media on neural involuntary attention switching in 2-year-old children , 2015, Behavioral and Brain Functions.

[7]  Yuhong Li,et al.  Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy , 2015, Experimental and therapeutic medicine.

[8]  Haobo Li,et al.  Intravenous Infusion of Dexmedetomidine Combined Isoflurane Inhalation Reduces Oxidative Stress and Potentiates Hypoxia Pulmonary Vasoconstriction during One-Lung Ventilation in Patients , 2015, Mediators of inflammation.

[9]  P. Dash,et al.  Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor , 2015, Journal of neurosurgical anesthesiology.

[10]  C. Cheung,et al.  Dexmedetomidine Analgesia Effects in Patients Undergoing Dental Implant Surgery and Its Impact on Postoperative Inflammatory and Oxidative Stress , 2015, Oxidative medicine and cellular longevity.

[11]  J. Zihl,et al.  Neuropsychology of Neuroendocrine Dysregulation after Traumatic Brain Injury , 2015, Journal of clinical medicine.

[12]  P. Kochanek,et al.  Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcome , 2015, Brain, Behavior, and Immunity.

[13]  Hong Liu,et al.  Effects of dexmedetomidine on patients undergoing radical gastrectomy. , 2015, The Journal of surgical research.

[14]  Xin Ma,et al.  [Effects of dexmedetomidine on recovery period of anesthesia and postoperative cognitive function after robot-assisted laparoscopicradical prostatectomy in the elderly people]. , 2015, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[15]  Ke Peng,et al.  Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: Meta-analysis of randomized controlled trials , 2014, Journal of Clinical Neuroscience.

[16]  Wang Wenjie,et al.  Effects of dexmedetomidine on outcomes following craniocerebral operation – A meta-analysis , 2014, Clinical Neurology and Neurosurgery.

[17]  Tianle Jiang,et al.  [Effects of different maintain doses of dexmedetomidine on plasma cortisol and glucose during anesthesia recovery period in patients undergoing uvulopalatopharyngoplasty under sevoflurane inhalation anesthesia]. , 2014, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[18]  Lei Zhang,et al.  Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. , 2014, Molecular medicine reports.

[19]  Hongsheng Zhu,et al.  Effect of dexmedetomidine or midazolam on postoperative S100β and mini-mental state examination under lower limbs surgery in old patients , 2014 .

[20]  Y. Li,et al.  Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle. , 2014, The Journal of surgical research.

[21]  Junmei Xu,et al.  Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A double-blind, randomized and placebo-controlled study , 2013, Upsala journal of medical sciences.

[22]  H. Mowafi,et al.  Efficacy of Dexmedetomidine in Suppressing Cardiovascular and Hormonal Responses to General Anaesthesia for Caesarean Delivery: A Dose-Response Study , 2013 .

[23]  Yongsuk Kim,et al.  Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy , 2013, Acta anaesthesiologica Scandinavica.

[24]  F. Martiniuk,et al.  The Effect of Intraoperative Infusion of Dexmedetomidine on the Quality of Recovery After Major Spinal Surgery , 2013, Journal of neurosurgical anesthesiology.

[25]  John H. Zhang,et al.  Effect of Dexmedetomidine on Brain Edema and Neurological Outcomes in Surgical Brain Injury in Rats , 2012, Anesthesia and analgesia.

[26]  Gao Xiao-feng.  Protective effect of dexmedetomidine on perioperative patients with intracranial spaceoccupying lesion , 2012 .

[27]  G. Stoll,et al.  α2-Adrenoceptors do not Mediate Neuroprotection in Acute Ischemic Stroke in Mice , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  S. Ben-Eliyahu,et al.  Improving Postoperative Immune Status and Resistance to Cancer Metastasis: A Combined Perioperative Approach of Immunostimulation and Prevention of Excessive Surgical Stress Responses , 2011, Annals of surgery.

[29]  P. Grammas,et al.  Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[30]  A. Omar,et al.  Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia. , 2011, Middle East journal of anaesthesiology.

[31]  G. D. del Zoppo.  Acute anti‐inflammatory approaches to ischemic stroke , 2010, Annals of the New York Academy of Sciences.

[32]  N. Sut,et al.  Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. , 2009, Journal of clinical anesthesia.

[33]  Shuang Wang,et al.  Perioperative Acute Ischemic Stroke in Noncardiac and Nonvascular Surgery: Incidence, Risk Factors, and Outcomes , 2009, Anesthesiology.

[34]  M. Cosar,et al.  The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. , 2009, Surgical neurology.

[35]  A. Zwinderman,et al.  Time‐Course of Cytokines During Delirium in Elderly Patients with Hip Fractures , 2008, Journal of the American Geriatrics Society.

[36]  M. Cosar,et al.  The influence of dexmedetomidine on ischemic rat hippocampus , 2008, Brain Research.

[37]  H. Başar,et al.  Dexmedetomidine Attenuates the Hemodynamic and Neuroendocrinal Responses to Skull-pin Head-holder Application During Craniotomy , 2008, Journal of neurosurgical anesthesiology.

[38]  T. Kossmann,et al.  Modulation of immune response by head injury. , 2007, Injury.

[39]  D. Sulemanji,et al.  Dexmedetomidine during coronary artery bypass grafting surgery: is it neuroprotective? – A preliminary study , 2007, Acta anaesthesiologica Scandinavica.

[40]  J. O'Callaghan,et al.  Divergent Roles for Tumor Necrosis Factor-α in the Brain , 2007, Journal of Neuroimmune Pharmacology.

[41]  J. O'Callaghan,et al.  Divergent roles for tumor necrosis factor-alpha in the brain. , 2007, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology.

[42]  D. Sakas,et al.  Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. , 2006, Current medicinal chemistry.

[43]  R. Aantaa,et al.  Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. , 2006, British journal of anaesthesia.

[44]  S. Robinson,et al.  TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer’s disease , 2006, Journal of Neural Transmission.

[45]  B. Delvi,et al.  Effect of small dose intravenous dexmedetomidine and/or local anaesthetic infiltration on haemodynamic responses to skull pin placement , 2006 .

[46]  J. Losy,et al.  [Cytokines in clinical and experimental ischemic stroke]. , 2004, Neurologia i neurochirurgia polska.

[47]  E. Kochs,et al.  Effect of the α2-Agonist Dexmedetomidine on Cerebral Neurotransmitter Concentrations during Cerebral Ischemia in Rats , 2002 .

[48]  P. Halligan,et al.  Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass? , 2001, The Annals of thoracic surgery.

[49]  E. Mascha,et al.  Relation between Perioperative Hypertension and Intracranial Hemorrhage after Craniotomy , 2000, Anesthesiology.

[50]  Kennedy Bc,et al.  Neuroendocrine and inflammatory aspects of surgery: do they affect outcome? , 1999 .

[51]  G. Hall,et al.  Neuroendocrine and inflammatory aspects of surgery: do they affect outcome? , 1998, European journal of anaesthesiology.

[52]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[53]  P. Steen,et al.  Dexmedetomidine, a potent alpha 2-agonist, does not affect neuronal damage following severe forebrain ischaemia in the rat. , 1995, European journal of anaesthesiology.

[54]  B. Siesjö,et al.  The influence of plasma glucose concentrations on ischemic brain damage is a threshold function , 1994, Neuroscience Letters.